Rank | Gene Set | Z-score |
---|---|---|
1 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 9.74951013 |
2 | indole-containing compound catabolic process (GO:0042436) | 9.17788526 |
3 | indolalkylamine catabolic process (GO:0046218) | 9.17788526 |
4 | tryptophan catabolic process (GO:0006569) | 9.17788526 |
5 | * seminiferous tubule development (GO:0072520) | 9.00746236 |
6 | positive regulation of protein sumoylation (GO:0033235) | 8.79360978 |
7 | positive regulation of type 2 immune response (GO:0002830) | 8.49058224 |
8 | negative regulation of T-helper cell differentiation (GO:0045623) | 8.28370225 |
9 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 8.28370225 |
10 | negative regulation of interleukin-10 production (GO:0032693) | 8.15369649 |
11 | tryptophan metabolic process (GO:0006568) | 7.94466576 |
12 | protein K11-linked deubiquitination (GO:0035871) | 7.84754287 |
13 | regulation of T-helper 2 cell differentiation (GO:0045628) | 7.30954790 |
14 | regulation of T-helper 1 cell differentiation (GO:0045625) | 7.06847804 |
15 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 6.76402535 |
16 | negative regulation of type 2 immune response (GO:0002829) | 6.63687369 |
17 | * single fertilization (GO:0007338) | 6.39068791 |
18 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 6.30683645 |
19 | negative regulation of interleukin-8 production (GO:0032717) | 6.26514720 |
20 | enteric nervous system development (GO:0048484) | 6.00312504 |
21 | cellular biogenic amine catabolic process (GO:0042402) | 5.93454701 |
22 | amine catabolic process (GO:0009310) | 5.93454701 |
23 | cAMP biosynthetic process (GO:0006171) | 5.92690247 |
24 | aromatic amino acid family catabolic process (GO:0009074) | 5.86271323 |
25 | indolalkylamine metabolic process (GO:0006586) | 5.78506561 |
26 | activation of protein kinase A activity (GO:0034199) | 5.68262322 |
27 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 5.58867979 |
28 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 5.40587533 |
29 | cellular response to ATP (GO:0071318) | 5.39965478 |
30 | synaptic transmission, dopaminergic (GO:0001963) | 5.38601435 |
31 | positive regulation of RNA splicing (GO:0033120) | 5.34215956 |
32 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 5.32772946 |
33 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 5.24003465 |
34 | regulation of protein sumoylation (GO:0033233) | 5.08705183 |
35 | benzene-containing compound metabolic process (GO:0042537) | 4.84918032 |
36 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.83903788 |
37 | negative regulation of T cell apoptotic process (GO:0070233) | 4.71115410 |
38 | digestion (GO:0007586) | 4.64468423 |
39 | negative regulation of endopeptidase activity (GO:0010951) | 4.63290771 |
40 | arachidonic acid secretion (GO:0050482) | 4.56884644 |
41 | icosanoid secretion (GO:0032309) | 4.56884644 |
42 | * fertilization (GO:0009566) | 4.52128982 |
43 | detection of chemical stimulus (GO:0009593) | 4.47516737 |
44 | regulation of type 2 immune response (GO:0002828) | 4.46105774 |
45 | N-acetylneuraminate metabolic process (GO:0006054) | 4.45632310 |
46 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.44720431 |
47 | negative regulation of peptidase activity (GO:0010466) | 4.42972821 |
48 | sialylation (GO:0097503) | 4.42233134 |
49 | detection of light stimulus involved in visual perception (GO:0050908) | 4.33780016 |
50 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.33780016 |
51 | aromatic amino acid family metabolic process (GO:0009072) | 4.29363669 |
52 | endothelial cell differentiation (GO:0045446) | 4.26066868 |
53 | positive regulation of mitochondrial fission (GO:0090141) | 4.24074071 |
54 | gonadal mesoderm development (GO:0007506) | 4.22927647 |
55 | negative regulation of protein autophosphorylation (GO:0031953) | 4.22642975 |
56 | defense response to bacterium (GO:0042742) | 4.20461649 |
57 | regulation of cAMP-mediated signaling (GO:0043949) | 4.14312979 |
58 | negative regulation of alpha-beta T cell activation (GO:0046636) | 4.06251763 |
59 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.01060278 |
60 | dendritic spine morphogenesis (GO:0060997) | 4.01041617 |
61 | positive thymic T cell selection (GO:0045059) | 3.99144734 |
62 | transepithelial transport (GO:0070633) | 3.98892500 |
63 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.98298731 |
64 | indole-containing compound metabolic process (GO:0042430) | 3.90795288 |
65 | thymic T cell selection (GO:0045061) | 3.88512498 |
66 | hepatocyte apoptotic process (GO:0097284) | 3.88297319 |
67 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.86371162 |
68 | righting reflex (GO:0060013) | 3.85595083 |
69 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.79046930 |
70 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.70857982 |
71 | male meiosis (GO:0007140) | 3.69671590 |
72 | regulation of T-helper 1 type immune response (GO:0002825) | 3.68932755 |
73 | GDP-mannose metabolic process (GO:0019673) | 3.67253007 |
74 | cytokinetic process (GO:0032506) | 3.60049452 |
75 | response to bacterium (GO:0009617) | 3.59870992 |
76 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.55927867 |
77 | reverse cholesterol transport (GO:0043691) | 3.54774209 |
78 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.54322845 |
79 | icosanoid transport (GO:0071715) | 3.51270586 |
80 | fatty acid derivative transport (GO:1901571) | 3.51270586 |
81 | positive regulation of interleukin-12 production (GO:0032735) | 3.50387695 |
82 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.47934000 |
83 | regulation of T-helper cell differentiation (GO:0045622) | 3.44439119 |
84 | negative regulation of glycogen metabolic process (GO:0070874) | 3.40972742 |
85 | leukotriene biosynthetic process (GO:0019370) | 3.39544027 |
86 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.36243435 |
87 | piRNA metabolic process (GO:0034587) | 3.35878350 |
88 | nephron tubule morphogenesis (GO:0072078) | 3.32079485 |
89 | nephron epithelium morphogenesis (GO:0072088) | 3.32079485 |
90 | sulfur amino acid catabolic process (GO:0000098) | 3.30678493 |
91 | phospholipid homeostasis (GO:0055091) | 3.27632749 |
92 | hyaluronan catabolic process (GO:0030214) | 3.27150181 |
93 | monoamine transport (GO:0015844) | 3.22288286 |
94 | regulation of mitochondrial fission (GO:0090140) | 3.21957816 |
95 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.17838024 |
96 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.17187914 |
97 | positive regulation of histone deacetylation (GO:0031065) | 3.16347611 |
98 | negative regulation of T cell differentiation (GO:0045581) | 3.15373429 |
99 | motile cilium assembly (GO:0044458) | 3.15289433 |
100 | regulation of macrophage activation (GO:0043030) | 3.14757045 |
101 | positive T cell selection (GO:0043368) | 3.13763593 |
102 | regulation of activated T cell proliferation (GO:0046006) | 3.12785979 |
103 | low-density lipoprotein particle clearance (GO:0034383) | 3.11316086 |
104 | neuronal ion channel clustering (GO:0045161) | 3.11014016 |
105 | O-glycan processing (GO:0016266) | 3.10879891 |
106 | response to dietary excess (GO:0002021) | 3.09069792 |
107 | negative regulation of interleukin-6 production (GO:0032715) | 3.06691290 |
108 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.05627031 |
109 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.05627031 |
110 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.04464777 |
111 | positive regulation of protein kinase C signaling (GO:0090037) | 3.01665537 |
112 | negative regulation of proteolysis (GO:0045861) | 3.00908281 |
113 | DNA methylation involved in gamete generation (GO:0043046) | 3.00751287 |
114 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.00113669 |
115 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.99328652 |
116 | T cell selection (GO:0045058) | 2.97296717 |
117 | phosphatidylglycerol metabolic process (GO:0046471) | 2.96449858 |
118 | glutathione biosynthetic process (GO:0006750) | 2.93051730 |
119 | rRNA methylation (GO:0031167) | 2.92639419 |
120 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.92233960 |
121 | retina layer formation (GO:0010842) | 2.91246734 |
122 | negative regulation of protein processing (GO:0010955) | 2.89383765 |
123 | negative regulation of protein maturation (GO:1903318) | 2.89383765 |
124 | phosphatidylserine metabolic process (GO:0006658) | 2.89185787 |
125 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.88232183 |
126 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.86875943 |
127 | DNA deamination (GO:0045006) | 2.86791086 |
128 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86461952 |
129 | cAMP metabolic process (GO:0046058) | 2.84987014 |
130 | neural tube formation (GO:0001841) | 2.84976953 |
131 | mitochondrial fusion (GO:0008053) | 2.84101029 |
132 | chemosensory behavior (GO:0007635) | 2.81389631 |
133 | regulation of lipoprotein metabolic process (GO:0050746) | 2.80431172 |
134 | glial cell proliferation (GO:0014009) | 2.79224658 |
135 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.79165195 |
136 | regulation of cholesterol storage (GO:0010885) | 2.77958438 |
137 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 2.77906330 |
138 | negative regulation of protein oligomerization (GO:0032460) | 2.76402894 |
139 | histone arginine methylation (GO:0034969) | 2.76359413 |
140 | positive regulation of protein deacetylation (GO:0090312) | 2.72803042 |
141 | L-serine transport (GO:0015825) | 2.72649793 |
142 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.71235914 |
143 | positive regulation of protein targeting to membrane (GO:0090314) | 2.71095323 |
144 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.70074551 |
145 | drug transmembrane transport (GO:0006855) | 2.69267823 |
146 | signal peptide processing (GO:0006465) | 2.69042607 |
147 | positive regulation of protein homooligomerization (GO:0032464) | 2.68267957 |
148 | behavioral response to nicotine (GO:0035095) | 2.66251931 |
149 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.65936371 |
150 | cyclic nucleotide biosynthetic process (GO:0009190) | 2.65750273 |
151 | alpha-linolenic acid metabolic process (GO:0036109) | 2.65520867 |
152 | vesicle targeting (GO:0006903) | 2.65471689 |
153 | negative regulation of hydrolase activity (GO:0051346) | 2.63076723 |
154 | regulation of endopeptidase activity (GO:0052548) | 2.61721265 |
155 | serine transport (GO:0032329) | 2.61688827 |
156 | regulation of T cell apoptotic process (GO:0070232) | 2.56289981 |
157 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.55500764 |
158 | regulation of interleukin-12 production (GO:0032655) | 2.55173664 |
159 | regulation of interleukin-10 production (GO:0032653) | 2.54876995 |
160 | valine metabolic process (GO:0006573) | 2.50072022 |
161 | regulation of peptidase activity (GO:0052547) | 2.49671175 |
162 | COPI coating of Golgi vesicle (GO:0048205) | 2.48735310 |
163 | Golgi transport vesicle coating (GO:0048200) | 2.48735310 |
164 | phagocytosis, recognition (GO:0006910) | 2.47409449 |
165 | complement activation, alternative pathway (GO:0006957) | 2.45303973 |
166 | regulation of beta-amyloid formation (GO:1902003) | 2.45260810 |
167 | high-density lipoprotein particle remodeling (GO:0034375) | 2.41711405 |
168 | hormone catabolic process (GO:0042447) | 2.40940612 |
169 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.40282978 |
170 | positive regulation of response to oxidative stress (GO:1902884) | 2.40282978 |
171 | negative regulation of T cell proliferation (GO:0042130) | 2.34409893 |
172 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.33774725 |
173 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.33616777 |
174 | cellular anion homeostasis (GO:0030002) | 2.33426058 |
175 | positive regulation of cholesterol transport (GO:0032376) | 2.31542610 |
176 | positive regulation of sterol transport (GO:0032373) | 2.31542610 |
177 | lipid catabolic process (GO:0016042) | 2.29802426 |
178 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.29196774 |
179 | peptide catabolic process (GO:0043171) | 2.24703052 |
180 | negative regulation of glucose import (GO:0046325) | 2.24151175 |
181 | lipid storage (GO:0019915) | 2.21039775 |
182 | response to misfolded protein (GO:0051788) | 2.20748104 |
183 | defense response to other organism (GO:0098542) | 2.20123677 |
184 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.20029193 |
185 | microglial cell activation (GO:0001774) | 2.19568372 |
186 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.18589778 |
187 | protein O-linked glycosylation (GO:0006493) | 2.18560440 |
188 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.17684168 |
189 | neutral amino acid transport (GO:0015804) | 2.17146920 |
190 | response to vitamin A (GO:0033189) | 2.14671567 |
191 | regulation of T cell tolerance induction (GO:0002664) | 16.3570075 |
192 | production of molecular mediator involved in inflammatory response (GO:0002532) | 16.3477411 |
193 | positive regulation of tolerance induction (GO:0002645) | 14.1453367 |
194 | regulation of tolerance induction (GO:0002643) | 12.4492892 |
195 | sperm capacitation (GO:0048240) | 12.1761918 |
196 | kynurenine metabolic process (GO:0070189) | 11.1031415 |
197 | tooth mineralization (GO:0034505) | 10.4010835 |
198 | regulation of chronic inflammatory response (GO:0002676) | 10.3311177 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 8.09632719 |
2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 6.79910750 |
3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.34560576 |
4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.29281153 |
5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.79875994 |
6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 3.29768349 |
7 | VDR_22108803_ChIP-Seq_LS180_Human | 3.13403511 |
8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.03775489 |
9 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 2.89301437 |
10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.85949739 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.63785155 |
12 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.62874255 |
13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53930339 |
14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.53872748 |
15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.36343244 |
16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27536681 |
17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.26485532 |
18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.26140571 |
19 | PHF8_20622854_ChIP-Seq_HELA_Human | 2.08987226 |
20 | * E2F1_20622854_ChIP-Seq_HELA_Human | 2.07413501 |
21 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.07279983 |
22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06787121 |
23 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.00740639 |
24 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.97574199 |
25 | * P68_20966046_ChIP-Seq_HELA_Human | 1.96996937 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96145438 |
27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90270432 |
28 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.90231329 |
29 | GATA1_19941826_ChIP-Seq_K562_Human | 1.86659469 |
30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.86344273 |
31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86325501 |
32 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.82127453 |
33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.81768107 |
34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81429700 |
35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.78345558 |
36 | SA1_27219007_Chip-Seq_Bcells_Human | 1.76912370 |
37 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75796914 |
38 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.75254162 |
39 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.74664717 |
40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.74068451 |
41 | MAF_26560356_Chip-Seq_TH2_Human | 1.72052835 |
42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70569052 |
43 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.69170658 |
44 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.66611199 |
45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.65904307 |
46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.65813371 |
47 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65180914 |
48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64802277 |
49 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.62091188 |
50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61483513 |
51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61350268 |
52 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.59039688 |
53 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.58410178 |
54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.55939526 |
55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.55838310 |
56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.55413692 |
57 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.53535186 |
58 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.50397095 |
59 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.50339762 |
60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49968119 |
61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49000582 |
62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48451796 |
63 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.47660013 |
64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47489043 |
65 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.47460016 |
66 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.47230144 |
67 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45737953 |
68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45641316 |
69 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.44731175 |
70 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.43127921 |
71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40243047 |
72 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.40091024 |
73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37568481 |
74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37507599 |
75 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36576556 |
76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35412327 |
77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35339692 |
78 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33488328 |
79 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.33053728 |
80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.31240630 |
81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.31084405 |
82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31004777 |
83 | MYC_22102868_ChIP-Seq_BL_Human | 1.28267676 |
84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.27517362 |
85 | * STAT1_17558387_ChIP-Seq_HELA_Human | 1.26245502 |
86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25584238 |
87 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.25213613 |
88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25048594 |
89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24111510 |
90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.23823387 |
91 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.22911096 |
92 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.20947162 |
93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20850091 |
94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19633394 |
95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19103427 |
96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.18879038 |
97 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18671279 |
98 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.18302996 |
99 | MAF_26560356_Chip-Seq_TH1_Human | 1.18275773 |
100 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16739341 |
101 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.15965810 |
102 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15789399 |
103 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.14923720 |
104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14912052 |
105 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.13697364 |
106 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13319540 |
107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13159300 |
108 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13116717 |
109 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13116717 |
110 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12957326 |
111 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12507899 |
112 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10888595 |
113 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10724898 |
114 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.10528203 |
115 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.10022336 |
116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09977221 |
117 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09487588 |
118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09425347 |
119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09379478 |
120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09231201 |
121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09231201 |
122 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09008196 |
123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08797068 |
124 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.08640075 |
125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08107649 |
126 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07799787 |
127 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.06715862 |
128 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06316950 |
129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05828174 |
130 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05422851 |
131 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05115385 |
132 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.05048755 |
133 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04902531 |
134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04774985 |
135 | P300_27268052_Chip-Seq_Bcells_Human | 1.04671649 |
136 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.03829809 |
137 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03767314 |
138 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03757542 |
139 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.03729966 |
140 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03269036 |
141 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02858905 |
142 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02573013 |
143 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02531597 |
144 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.01558128 |
145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01180490 |
146 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01106770 |
147 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00110367 |
148 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99795676 |
149 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99738776 |
150 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99461734 |
151 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99339240 |
152 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.98596090 |
153 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98008304 |
154 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97781067 |
155 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96768956 |
156 | * SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.96727216 |
157 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95888045 |
158 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95812754 |
159 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95585851 |
160 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.95086397 |
161 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94357376 |
162 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93739509 |
163 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.93282794 |
164 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92762705 |
165 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92756901 |
166 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92366818 |
167 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92185468 |
168 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91915412 |
169 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90329624 |
170 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90153742 |
171 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.89666377 |
172 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89476761 |
173 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88557959 |
174 | MYB_26560356_Chip-Seq_TH2_Human | 0.88492730 |
175 | * BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.87711976 |
176 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87668524 |
177 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87275827 |
178 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.84783620 |
179 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84551523 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008961_abnormal_basal_metabolism | 7.46145377 |
2 | MP0005084_abnormal_gallbladder_morpholo | 7.32221418 |
3 | MP0003303_peritoneal_inflammation | 6.27592496 |
4 | MP0002254_reproductive_system_inflammat | 5.68932659 |
5 | MP0003195_calcinosis | 4.78125405 |
6 | MP0005058_abnormal_lysosome_morphology | 3.61738941 |
7 | MP0004043_abnormal_pH_regulation | 3.43094802 |
8 | MP0005410_abnormal_fertilization | 3.36628219 |
9 | MP0003136_yellow_coat_color | 3.17570972 |
10 | MP0002139_abnormal_hepatobiliary_system | 3.03142869 |
11 | MP0010234_abnormal_vibrissa_follicle | 2.80388906 |
12 | MP0001986_abnormal_taste_sensitivity | 2.80160472 |
13 | MP0005083_abnormal_biliary_tract | 2.78655022 |
14 | MP0000003_abnormal_adipose_tissue | 2.68385418 |
15 | MP0003252_abnormal_bile_duct | 2.41323995 |
16 | MP0005671_abnormal_response_to | 2.39690030 |
17 | MP0003566_abnormal_cell_adhesion | 2.19476117 |
18 | MP0005423_abnormal_somatic_nervous | 2.17235452 |
19 | MP0004185_abnormal_adipocyte_glucose | 2.16740535 |
20 | MP0003329_amyloid_beta_deposits | 2.16463505 |
21 | MP0002168_other_aberrant_phenotype | 2.15062144 |
22 | MP0003646_muscle_fatigue | 2.14655868 |
23 | MP0002928_abnormal_bile_duct | 2.11121126 |
24 | MP0004133_heterotaxia | 2.10117918 |
25 | MP0003300_gastrointestinal_ulcer | 2.09348271 |
26 | MP0000604_amyloidosis | 2.06033457 |
27 | MP0001853_heart_inflammation | 1.94209932 |
28 | MP0005448_abnormal_energy_balance | 1.93666480 |
29 | MP0004130_abnormal_muscle_cell | 1.89257252 |
30 | MP0002933_joint_inflammation | 1.88123265 |
31 | MP0005375_adipose_tissue_phenotype | 1.76845170 |
32 | MP0003878_abnormal_ear_physiology | 1.68672046 |
33 | MP0005377_hearing/vestibular/ear_phenot | 1.68672046 |
34 | MP0002876_abnormal_thyroid_physiology | 1.62753332 |
35 | MP0005451_abnormal_body_composition | 1.62562726 |
36 | MP0000470_abnormal_stomach_morphology | 1.61156802 |
37 | MP0000013_abnormal_adipose_tissue | 1.60729728 |
38 | MP0001765_abnormal_ion_homeostasis | 1.59834246 |
39 | MP0004381_abnormal_hair_follicle | 1.59778587 |
40 | MP0010329_abnormal_lipoprotein_level | 1.58977905 |
41 | MP0005174_abnormal_tail_pigmentation | 1.58646432 |
42 | MP0003763_abnormal_thymus_physiology | 1.57531643 |
43 | MP0003690_abnormal_glial_cell | 1.57337663 |
44 | MP0001270_distended_abdomen | 1.55232933 |
45 | MP0001968_abnormal_touch/_nociception | 1.51333117 |
46 | MP0000685_abnormal_immune_system | 1.46665616 |
47 | MP0006082_CNS_inflammation | 1.45783982 |
48 | MP0002089_abnormal_postnatal_growth/wei | 1.44350192 |
49 | MP0003943_abnormal_hepatobiliary_system | 1.41437593 |
50 | MP0005670_abnormal_white_adipose | 1.39960277 |
51 | MP0001501_abnormal_sleep_pattern | 1.39874927 |
52 | MP0002896_abnormal_bone_mineralization | 1.34488281 |
53 | MP0002009_preneoplasia | 1.33202758 |
54 | MP0001533_abnormal_skeleton_physiology | 1.31101577 |
55 | MP0005360_urolithiasis | 1.29657997 |
56 | MP0002736_abnormal_nociception_after | 1.29475252 |
57 | MP0002751_abnormal_autonomic_nervous | 1.27499966 |
58 | MP0000372_irregular_coat_pigmentation | 1.26664194 |
59 | MP0006072_abnormal_retinal_apoptosis | 1.26218983 |
60 | MP0005551_abnormal_eye_electrophysiolog | 1.25934855 |
61 | MP0003724_increased_susceptibility_to | 1.25125878 |
62 | MP0001958_emphysema | 1.24433289 |
63 | MP0002419_abnormal_innate_immunity | 1.22695066 |
64 | MP0001835_abnormal_antigen_presentation | 1.21744847 |
65 | MP0005666_abnormal_adipose_tissue | 1.21144666 |
66 | MP0005397_hematopoietic_system_phenotyp | 1.20854489 |
67 | MP0001545_abnormal_hematopoietic_system | 1.20854489 |
68 | MP0008438_abnormal_cutaneous_collagen | 1.20411508 |
69 | MP0003718_maternal_effect | 1.19901924 |
70 | MP0009379_abnormal_foot_pigmentation | 1.19802916 |
71 | MP0002420_abnormal_adaptive_immunity | 1.19354996 |
72 | MP0009643_abnormal_urine_homeostasis | 1.18028563 |
73 | MP0002452_abnormal_antigen_presenting | 1.17699534 |
74 | MP0002405_respiratory_system_inflammati | 1.14113106 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 1.13916468 |
76 | MP0005365_abnormal_bile_salt | 1.13698628 |
77 | MP0005164_abnormal_response_to | 1.09611948 |
78 | MP0009785_altered_susceptibility_to | 1.08164175 |
79 | MP0003448_altered_tumor_morphology | 1.07866553 |
80 | MP0005220_abnormal_exocrine_pancreas | 1.06580764 |
81 | MP0005503_abnormal_tendon_morphology | 1.05169138 |
82 | MP0004134_abnormal_chest_morphology | 1.02707300 |
83 | MP0002998_abnormal_bone_remodeling | 1.02702007 |
84 | MP0002398_abnormal_bone_marrow | 1.02402308 |
85 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00803402 |
86 | MP0002210_abnormal_sex_determination | 1.00324412 |
87 | MP0001929_abnormal_gametogenesis | 1.00209481 |
88 | MP0000703_abnormal_thymus_morphology | 0.99509764 |
89 | MP0000716_abnormal_immune_system | 0.97256700 |
90 | MP0000767_abnormal_smooth_muscle | 0.97180588 |
91 | MP0004264_abnormal_extraembryonic_tissu | 0.97097500 |
92 | MP0003191_abnormal_cellular_cholesterol | 0.95492716 |
93 | MP0009278_abnormal_bone_marrow | 0.95242119 |
94 | MP0002735_abnormal_chemical_nociception | 0.94323866 |
95 | MP0002722_abnormal_immune_system | 0.94244662 |
96 | MP0009384_cardiac_valve_regurgitation | 0.93901649 |
97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93480788 |
98 | MP0002136_abnormal_kidney_physiology | 0.91050288 |
99 | MP0002429_abnormal_blood_cell | 0.90299950 |
100 | MP0000678_abnormal_parathyroid_gland | 0.90180166 |
101 | MP0001440_abnormal_grooming_behavior | 0.89007491 |
102 | MP0004858_abnormal_nervous_system | 0.88772528 |
103 | MP0009780_abnormal_chondrocyte_physiolo | 0.88250586 |
104 | MP0002148_abnormal_hypersensitivity_rea | 0.88059789 |
105 | MP0005000_abnormal_immune_tolerance | 0.86034299 |
106 | MP0005171_absent_coat_pigmentation | 0.85959790 |
107 | MP0005275_abnormal_skin_tensile | 0.85844471 |
108 | MP0001851_eye_inflammation | 0.85145569 |
109 | MP0002723_abnormal_immune_serum | 0.84759427 |
110 | MP0009764_decreased_sensitivity_to | 0.84508773 |
111 | MP0002118_abnormal_lipid_homeostasis | 0.83522667 |
112 | MP0005334_abnormal_fat_pad | 0.82856911 |
113 | MP0001756_abnormal_urination | 0.82356599 |
114 | MP0000534_abnormal_ureter_morphology | 0.81643153 |
115 | MP0002132_abnormal_respiratory_system | 0.80937915 |
116 | MP0003705_abnormal_hypodermis_morpholog | 0.80766838 |
117 | MP0000689_abnormal_spleen_morphology | 0.80754484 |
118 | MP0006054_spinal_hemorrhage | 0.80491978 |
119 | MP0003045_fibrosis | 0.79601471 |
120 | MP0005025_abnormal_response_to | 0.79477090 |
121 | MP0000343_altered_response_to | 0.79055911 |
122 | MP0005319_abnormal_enzyme/_coenzyme | 0.78984414 |
123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78941777 |
124 | MP0010368_abnormal_lymphatic_system | 0.78430777 |
125 | MP0003075_altered_response_to | 0.78352314 |
126 | MP0000015_abnormal_ear_pigmentation | 0.78299410 |
127 | MP0002693_abnormal_pancreas_physiology | 0.78168298 |
128 | MP0005379_endocrine/exocrine_gland_phen | 0.78018050 |
129 | MP0003698_abnormal_male_reproductive | 0.77759817 |
130 | MP0001819_abnormal_immune_cell | 0.77640135 |
131 | MP0008569_lethality_at_weaning | 0.77584194 |
132 | MP0000249_abnormal_blood_vessel | 0.76958035 |
133 | MP0005636_abnormal_mineral_homeostasis | 0.76824998 |
134 | MP0005623_abnormal_meninges_morphology | 0.76766087 |
135 | MP0008872_abnormal_physiological_respon | 0.75786245 |
136 | MP0001790_abnormal_immune_system | 0.75675690 |
137 | MP0005387_immune_system_phenotype | 0.75675690 |
138 | MP0003638_abnormal_response/metabolism_ | 0.75461449 |
139 | MP0002909_abnormal_adrenal_gland | 0.75261417 |
140 | MP0001800_abnormal_humoral_immune | 0.75065204 |
141 | MP0005395_other_phenotype | 0.74397344 |
142 | MP0005085_abnormal_gallbladder_physiolo | 0.74177293 |
143 | MP0001845_abnormal_inflammatory_respons | 0.74070753 |
144 | MP0000609_abnormal_liver_physiology | 0.73298362 |
145 | MP0005464_abnormal_platelet_physiology | 0.72162967 |
146 | MP0001879_abnormal_lymphatic_vessel | 0.72120045 |
147 | MP0003436_decreased_susceptibility_to | 0.71978012 |
148 | MP0003693_abnormal_embryo_hatching | 0.71319443 |
149 | MP0003091_abnormal_cell_migration | 0.69173592 |
150 | MP0005310_abnormal_salivary_gland | 0.68941956 |
151 | MP0000371_diluted_coat_color | 0.68702608 |
152 | MP0002161_abnormal_fertility/fecundity | 0.68516512 |
153 | MP0000858_altered_metastatic_potential | 0.68243154 |
154 | MP0002113_abnormal_skeleton_development | 0.68169634 |
155 | MP0002971_abnormal_brown_adipose | 0.68012851 |
156 | MP0005332_abnormal_amino_acid | 0.67501580 |
157 | MP0008469_abnormal_protein_level | 0.67205018 |
158 | MP0009840_abnormal_foam_cell | 0.67181091 |
159 | MP0004947_skin_inflammation | 0.66801822 |
160 | MP0001529_abnormal_vocalization | 0.66731278 |
161 | MP0003806_abnormal_nucleotide_metabolis | 0.66424538 |
162 | MP0004019_abnormal_vitamin_homeostasis | 0.65509884 |
163 | MP0002138_abnormal_hepatobiliary_system | 0.65420256 |
164 | MP0003866_abnormal_defecation | 0.65382162 |
165 | MP0010155_abnormal_intestine_physiology | 0.65212157 |
166 | MP0002095_abnormal_skin_pigmentation | 0.64496649 |
167 | MP0005076_abnormal_cell_differentiation | 0.64437980 |
168 | MP0009115_abnormal_fat_cell | 0.62402939 |
169 | MP0001905_abnormal_dopamine_level | 0.61043930 |
170 | MP0002277_abnormal_respiratory_mucosa | 0.57694779 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Amelogenesis imperfecta (HP:0000705) | 6.84094305 |
2 | Myocardial infarction (HP:0001658) | 5.28940746 |
3 | Polyuria (HP:0000103) | 4.98302192 |
4 | Vascular calcification (HP:0004934) | 4.66455444 |
5 | Attenuation of retinal blood vessels (HP:0007843) | 4.60495454 |
6 | Overgrowth (HP:0001548) | 4.49310678 |
7 | Abnormality of dental color (HP:0011073) | 4.45928361 |
8 | Hypophosphatemic rickets (HP:0004912) | 4.37273787 |
9 | Cardiovascular calcification (HP:0011915) | 4.33300060 |
10 | Abnormal urine output (HP:0012590) | 4.19927164 |
11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.17282804 |
12 | Abnormality of renal resorption (HP:0011038) | 4.16610095 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.13520423 |
14 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.11508854 |
15 | Decreased central vision (HP:0007663) | 3.91841535 |
16 | Facial shape deformation (HP:0011334) | 3.88224528 |
17 | Potter facies (HP:0002009) | 3.88224528 |
18 | Pendular nystagmus (HP:0012043) | 3.84309286 |
19 | Agitation (HP:0000713) | 3.78919996 |
20 | Complement deficiency (HP:0004431) | 3.52755982 |
21 | Abnormality of renal excretion (HP:0011036) | 3.48356702 |
22 | Round ear (HP:0100830) | 3.26869288 |
23 | Malnutrition (HP:0004395) | 3.23303707 |
24 | Mutism (HP:0002300) | 3.19526326 |
25 | Eczematoid dermatitis (HP:0000976) | 3.17380978 |
26 | Neurofibrillary tangles (HP:0002185) | 3.16592302 |
27 | Panhypogammaglobulinemia (HP:0003139) | 3.12159599 |
28 | Hypoproteinemia (HP:0003075) | 3.05088321 |
29 | Abnormality of midbrain morphology (HP:0002418) | 3.02251382 |
30 | Molar tooth sign on MRI (HP:0002419) | 3.02251382 |
31 | Widely patent fontanelles and sutures (HP:0004492) | 3.00546284 |
32 | Choroideremia (HP:0001139) | 2.98340316 |
33 | Autoimmune thrombocytopenia (HP:0001973) | 2.98009093 |
34 | Abnormality of the dental pulp (HP:0006479) | 2.93447707 |
35 | Cerebral inclusion bodies (HP:0100314) | 2.91029077 |
36 | Intestinal fistula (HP:0100819) | 2.78254433 |
37 | Personality changes (HP:0000751) | 2.76774028 |
38 | IgM deficiency (HP:0002850) | 2.68701157 |
39 | Lip pit (HP:0100267) | 2.65962710 |
40 | Rickets (HP:0002748) | 2.65273413 |
41 | Depressed nasal tip (HP:0000437) | 2.63955399 |
42 | Abnormality of the fingertips (HP:0001211) | 2.63484276 |
43 | Abnormality of the costochondral junction (HP:0000919) | 2.60154836 |
44 | Delayed epiphyseal ossification (HP:0002663) | 2.58177162 |
45 | Disinhibition (HP:0000734) | 2.55208425 |
46 | Hypoalphalipoproteinemia (HP:0003233) | 2.55014142 |
47 | Abnormality of complement system (HP:0005339) | 2.54927896 |
48 | Abnormality of the fovea (HP:0000493) | 2.54267886 |
49 | Toxemia of pregnancy (HP:0100603) | 2.54225731 |
50 | Alveolar cell carcinoma (HP:0006519) | 2.52547148 |
51 | Abnormality of the pons (HP:0007361) | 2.50945785 |
52 | Epiphyseal dysplasia (HP:0002656) | 2.50380069 |
53 | Infantile muscular hypotonia (HP:0008947) | 2.49671695 |
54 | Abnormality of the renal collecting system (HP:0004742) | 2.49151786 |
55 | Abnormality of DNA repair (HP:0003254) | 2.47837959 |
56 | Nephronophthisis (HP:0000090) | 2.47478550 |
57 | Hypoplasia of the pons (HP:0012110) | 2.44984116 |
58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44773058 |
59 | Restlessness (HP:0000711) | 2.43121364 |
60 | Sparse lateral eyebrow (HP:0005338) | 2.42874792 |
61 | Abnormal tarsal ossification (HP:0008369) | 2.42833049 |
62 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.40909177 |
63 | Congenital stationary night blindness (HP:0007642) | 2.40519981 |
64 | Recurrent bacterial skin infections (HP:0005406) | 2.39997153 |
65 | Agammaglobulinemia (HP:0004432) | 2.38473191 |
66 | Duplicated collecting system (HP:0000081) | 2.37743623 |
67 | Metaphyseal cupping (HP:0003021) | 2.37681709 |
68 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.37094911 |
69 | Oligomenorrhea (HP:0000876) | 2.36374529 |
70 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.36085929 |
71 | Prominent nose (HP:0000448) | 2.35523999 |
72 | Vacuolated lymphocytes (HP:0001922) | 2.35405141 |
73 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.34403696 |
74 | Acanthosis nigricans (HP:0000956) | 2.33730276 |
75 | Increased cerebral lipofuscin (HP:0011813) | 2.33208133 |
76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29587703 |
77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29587703 |
78 | Xanthomatosis (HP:0000991) | 2.28289747 |
79 | Neoplasm of the heart (HP:0100544) | 2.26485646 |
80 | Ureteral stenosis (HP:0000071) | 2.23791763 |
81 | Hemorrhage of the eye (HP:0011885) | 2.23670026 |
82 | Abnormality of macrophages (HP:0004311) | 2.23260644 |
83 | Acanthocytosis (HP:0001927) | 2.22508960 |
84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22429561 |
85 | Abnormality of purine metabolism (HP:0004352) | 2.21449879 |
86 | Enlarged epiphyses (HP:0010580) | 2.19899810 |
87 | Progressive neurologic deterioration (HP:0002344) | 2.18945784 |
88 | Hyporeflexia of lower limbs (HP:0002600) | 2.18383574 |
89 | Tachypnea (HP:0002789) | 2.17550734 |
90 | Supranuclear gaze palsy (HP:0000605) | 2.16765055 |
91 | Abnormality of the common coagulation pathway (HP:0010990) | 2.15908199 |
92 | Acute hepatic failure (HP:0006554) | 2.14934390 |
93 | Easy fatigability (HP:0003388) | 2.14004118 |
94 | Protuberant abdomen (HP:0001538) | 2.12746170 |
95 | Osteomalacia (HP:0002749) | 2.09684263 |
96 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.07933436 |
97 | Intention tremor (HP:0002080) | 2.06596541 |
98 | Recurrent fungal infections (HP:0002841) | 2.06581530 |
99 | Ureteral obstruction (HP:0006000) | 2.04227036 |
100 | Abnormal number of erythroid precursors (HP:0012131) | 2.03569632 |
101 | Increased corneal curvature (HP:0100692) | 2.03311868 |
102 | Keratoconus (HP:0000563) | 2.03311868 |
103 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02631265 |
104 | Tubular atrophy (HP:0000092) | 2.00761460 |
105 | Choreoathetosis (HP:0001266) | 2.00337162 |
106 | Severe combined immunodeficiency (HP:0004430) | 2.00247472 |
107 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.00114550 |
108 | Hypoparathyroidism (HP:0000829) | 1.99456036 |
109 | Myopathic facies (HP:0002058) | 1.99300542 |
110 | Abnormality of the renal medulla (HP:0100957) | 1.97197196 |
111 | Abnormality of the neuromuscular junction (HP:0003398) | 1.96747476 |
112 | Fatigable weakness (HP:0003473) | 1.96747476 |
113 | Macular degeneration (HP:0000608) | 1.96477945 |
114 | Nasal polyposis (HP:0100582) | 1.95228188 |
115 | Type II lissencephaly (HP:0007260) | 1.94129565 |
116 | Absent thumb (HP:0009777) | 1.93458314 |
117 | Ectopia lentis (HP:0001083) | 1.93059206 |
118 | Recurrent abscess formation (HP:0002722) | 1.92345555 |
119 | Dysostosis multiplex (HP:0000943) | 1.91899542 |
120 | Flat acetabular roof (HP:0003180) | 1.91650266 |
121 | Aplasia of the musculature (HP:0100854) | 1.91479604 |
122 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91128607 |
123 | Apathy (HP:0000741) | 1.90807873 |
124 | Colitis (HP:0002583) | 1.90708735 |
125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90556949 |
126 | Deep venous thrombosis (HP:0002625) | 1.90116091 |
127 | Type 2 muscle fiber atrophy (HP:0003554) | 1.89977020 |
128 | Cortical dysplasia (HP:0002539) | 1.89038135 |
129 | Systemic lupus erythematosus (HP:0002725) | 1.86567446 |
130 | Small epiphyses (HP:0010585) | 1.85864396 |
131 | Hypertriglyceridemia (HP:0002155) | 1.83948209 |
132 | Severe visual impairment (HP:0001141) | 1.83879459 |
133 | T lymphocytopenia (HP:0005403) | 1.83149132 |
134 | Increased connective tissue (HP:0009025) | 1.83082268 |
135 | Petechiae (HP:0000967) | 1.82110193 |
136 | Polar cataract (HP:0010696) | 1.80968871 |
137 | Abnormality of the femoral head (HP:0003368) | 1.80636247 |
138 | Abnormality of urine glucose concentration (HP:0011016) | 1.79904454 |
139 | Glycosuria (HP:0003076) | 1.79904454 |
140 | Diminished motivation (HP:0000745) | 1.79593907 |
141 | Wide cranial sutures (HP:0010537) | 1.79560389 |
142 | Ovoid vertebral bodies (HP:0003300) | 1.78582704 |
143 | J-shaped sella turcica (HP:0002680) | 1.78009834 |
144 | Ectopic kidney (HP:0000086) | 1.76662513 |
145 | Hyperphosphatemia (HP:0002905) | 1.76472656 |
146 | Mucopolysacchariduria (HP:0008155) | 1.74787153 |
147 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74787153 |
148 | Abnormality of the nasal mucosa (HP:0000433) | 1.74587663 |
149 | Broad face (HP:0000283) | 1.74587303 |
150 | Polydipsia (HP:0001959) | 1.74027993 |
151 | Abnormal drinking behavior (HP:0030082) | 1.74027993 |
152 | Joint stiffness (HP:0001387) | 1.73484525 |
153 | Peripheral demyelination (HP:0011096) | 1.73294053 |
154 | Deformed sella turcica (HP:0002681) | 1.72744472 |
155 | Absent frontal sinuses (HP:0002688) | 1.72588434 |
156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72086711 |
157 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71995416 |
158 | Gastrointestinal infarctions (HP:0005244) | 1.71717476 |
159 | Muscle fiber atrophy (HP:0100295) | 1.71647106 |
160 | Impulsivity (HP:0100710) | 1.71259853 |
161 | Abnormal foot bone ossification (HP:0010675) | 1.71075781 |
162 | Irregular epiphyses (HP:0010582) | 1.70999866 |
163 | Hemiplegia (HP:0002301) | 1.70960502 |
164 | Self-mutilation (HP:0000742) | 1.70892950 |
165 | Esophageal varix (HP:0002040) | 1.70845813 |
166 | Abnormal urine phosphate concentration (HP:0012599) | 1.70630514 |
167 | Difficulty running (HP:0009046) | 1.69789733 |
168 | Hyperglycemia (HP:0003074) | 1.69582594 |
169 | Abnormality of T cells (HP:0002843) | 1.69388167 |
170 | Hyperphosphaturia (HP:0003109) | 1.68475323 |
171 | Rib fusion (HP:0000902) | 1.68361841 |
172 | Short 5th finger (HP:0009237) | 1.68246244 |
173 | Poikiloderma (HP:0001029) | 1.68176751 |
174 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.67918215 |
175 | Exercise-induced myalgia (HP:0003738) | 1.67469351 |
176 | Mesangial abnormality (HP:0001966) | 1.66661779 |
177 | Carpal bone hypoplasia (HP:0001498) | 1.66617648 |
178 | Hypopigmentation of the fundus (HP:0007894) | 1.66429365 |
179 | Intrahepatic cholestasis (HP:0001406) | 1.66075878 |
180 | Abnormality of lateral ventricle (HP:0030047) | 1.65961991 |
181 | Hypoplastic ischia (HP:0003175) | 1.65775836 |
182 | Large earlobe (HP:0009748) | 1.65495662 |
183 | Thin bony cortex (HP:0002753) | 1.65438610 |
184 | Gout (HP:0001997) | 1.64617630 |
185 | Drooling (HP:0002307) | 1.64417766 |
186 | Excessive salivation (HP:0003781) | 1.64355770 |
187 | Peritonitis (HP:0002586) | 1.62667009 |
188 | Polygenic inheritance (HP:0010982) | 1.59884828 |
189 | Premature rupture of membranes (HP:0001788) | 1.59669006 |
190 | Hypophosphatemia (HP:0002148) | 1.59577594 |
191 | Metaphyseal irregularity (HP:0003025) | 1.59129490 |
192 | Inappropriate behavior (HP:0000719) | 1.58215841 |
193 | Abnormality of the lumbar spine (HP:0100712) | 1.56353783 |
194 | Flattened epiphyses (HP:0003071) | 1.56004846 |
195 | Abdominal distention (HP:0003270) | 1.55754958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK2 | 7.29803162 |
2 | BMPR2 | 6.87263750 |
3 | MAP4K1 | 6.03660532 |
4 | MST4 | 3.65785589 |
5 | DMPK | 3.12268835 |
6 | EPHB1 | 3.05664800 |
7 | ERN1 | 3.01777338 |
8 | TRIB3 | 2.40069528 |
9 | SIK1 | 2.23094229 |
10 | LRRK2 | 2.17313033 |
11 | TXK | 2.09840416 |
12 | PTK6 | 1.94588740 |
13 | MAP3K11 | 1.92073018 |
14 | MUSK | 1.91154165 |
15 | LMTK2 | 1.87943287 |
16 | FGFR4 | 1.86873564 |
17 | GSK3A | 1.82354986 |
18 | STK10 | 1.76029988 |
19 | VRK2 | 1.65559224 |
20 | LATS2 | 1.63126274 |
21 | TLK1 | 1.61409139 |
22 | RIPK4 | 1.59219114 |
23 | FER | 1.57691099 |
24 | ERBB3 | 1.54906243 |
25 | PDGFRA | 1.54172669 |
26 | ACVR1B | 1.52333744 |
27 | TAOK3 | 1.46824256 |
28 | TESK2 | 1.46144729 |
29 | PLK2 | 1.41302687 |
30 | EPHA2 | 1.41064891 |
31 | CDC42BPA | 1.39944067 |
32 | NEK2 | 1.39438937 |
33 | TBK1 | 1.33151212 |
34 | FGFR3 | 1.32988534 |
35 | BMX | 1.28625908 |
36 | CDK12 | 1.27349988 |
37 | GRK6 | 1.25398325 |
38 | EPHA3 | 1.24835545 |
39 | FLT3 | 1.23041692 |
40 | RET | 1.21792795 |
41 | NTRK1 | 1.20728667 |
42 | IKBKB | 1.20181097 |
43 | PTK2B | 1.19922474 |
44 | MAPK15 | 1.13627672 |
45 | DDR2 | 1.13007954 |
46 | PKN2 | 1.12397426 |
47 | PAK4 | 1.12300465 |
48 | IKBKE | 1.07461395 |
49 | IRAK1 | 1.01976071 |
50 | EPHB2 | 1.00544405 |
51 | BLK | 1.00404518 |
52 | IRAK3 | 1.00303215 |
53 | IRAK4 | 1.00128241 |
54 | ADRBK2 | 1.00010542 |
55 | WNK4 | 0.99188104 |
56 | HIPK2 | 0.98145830 |
57 | MAP2K6 | 0.97907162 |
58 | FGFR2 | 0.96792604 |
59 | STK38L | 0.96787059 |
60 | ITK | 0.95840735 |
61 | PRKD2 | 0.95821290 |
62 | MAP3K2 | 0.95314407 |
63 | CHUK | 0.95209869 |
64 | JAK1 | 0.93949350 |
65 | STK16 | 0.93086269 |
66 | PLK4 | 0.92942367 |
67 | RPS6KA6 | 0.91513205 |
68 | INSR | 0.90261087 |
69 | ZAK | 0.90068852 |
70 | BTK | 0.89742945 |
71 | TNK2 | 0.89010271 |
72 | STK39 | 0.87408647 |
73 | MAP3K14 | 0.87196597 |
74 | FRK | 0.84846446 |
75 | NME2 | 0.82609234 |
76 | ALK | 0.78590181 |
77 | KDR | 0.78550598 |
78 | NME1 | 0.78340535 |
79 | PAK3 | 0.78208766 |
80 | PRKCH | 0.78113053 |
81 | PTK2 | 0.75821480 |
82 | RPS6KL1 | 0.75679639 |
83 | RPS6KC1 | 0.75679639 |
84 | GRK1 | 0.75575528 |
85 | TTN | 0.74657707 |
86 | TESK1 | 0.74333477 |
87 | MYLK | 0.73509506 |
88 | ZAP70 | 0.72489282 |
89 | MAP3K5 | 0.72310091 |
90 | JAK2 | 0.69981579 |
91 | MAP3K7 | 0.69486429 |
92 | MAP3K6 | 0.69275488 |
93 | TGFBR2 | 0.69153218 |
94 | MAP2K1 | 0.68710612 |
95 | SIK2 | 0.68110063 |
96 | KIT | 0.68016591 |
97 | PDGFRB | 0.66797504 |
98 | BCKDK | 0.66402458 |
99 | CDK6 | 0.63819658 |
100 | TYRO3 | 0.62064771 |
101 | NEK9 | 0.61921557 |
102 | ADRBK1 | 0.60663057 |
103 | JAK3 | 0.60311974 |
104 | STK24 | 0.59909773 |
105 | LYN | 0.59192740 |
106 | SMG1 | 0.58997170 |
107 | IRAK2 | 0.58211749 |
108 | WNK1 | 0.57007533 |
109 | MAP3K12 | 0.54956016 |
110 | SYK | 0.54569496 |
111 | CSK | 0.53562536 |
112 | MAPKAPK3 | 0.53331202 |
113 | LCK | 0.53188907 |
114 | PAK2 | 0.50682363 |
115 | PRKAA1 | 0.50423071 |
116 | CDK9 | 0.50224249 |
117 | CDK8 | 0.49878954 |
118 | HCK | 0.49440230 |
119 | PKN1 | 0.48046033 |
120 | WNK3 | 0.48017826 |
121 | PDK3 | 0.47712547 |
122 | PDK4 | 0.47712547 |
123 | TYK2 | 0.47671015 |
124 | CAMK1G | 0.47665227 |
125 | STK3 | 0.47507237 |
126 | MAPK11 | 0.47028001 |
127 | PRKD1 | 0.46820594 |
128 | PRKCQ | 0.46434576 |
129 | BMPR1B | 0.44458374 |
130 | PIM1 | 0.44163792 |
131 | EEF2K | 0.43875788 |
132 | MELK | 0.43257572 |
133 | MARK3 | 0.41516657 |
134 | RIPK1 | 0.40354126 |
135 | ICK | 0.39586462 |
136 | INSRR | 0.39069492 |
137 | TAOK1 | 0.38791302 |
138 | VRK1 | 0.38309169 |
139 | TGFBR1 | 0.38286416 |
140 | FGFR1 | 0.38192193 |
141 | CAMK1 | 0.37840241 |
142 | PRKACG | 0.37319033 |
143 | TEC | 0.37280894 |
144 | AKT3 | 0.37219263 |
145 | STK38 | 0.36986921 |
146 | PDK1 | 0.36525352 |
147 | PRKACA | 0.36302822 |
148 | CCNB1 | 0.35913377 |
149 | CHEK2 | 0.35671451 |
150 | NTRK3 | 0.35378273 |
151 | MAPK3 | 0.35112291 |
152 | RPS6KA1 | 0.34449166 |
153 | CDK5 | 0.33507824 |
154 | MTOR | 0.33361555 |
155 | IGF1R | 0.33360176 |
156 | PRKG2 | 0.32864353 |
157 | SGK3 | 0.32790290 |
158 | EGFR | 0.31884231 |
159 | ILK | 0.31811172 |
160 | SRC | 0.31169956 |
161 | GSK3B | 0.29906960 |
162 | CDK7 | 0.29503203 |
163 | MAP3K1 | 0.28722860 |
164 | GRK7 | 0.28676171 |
165 | MARK2 | 0.28659858 |
166 | RPS6KA2 | 0.28006376 |
167 | PRKCA | 0.26218850 |
168 | MAPK13 | 0.25824527 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.87565460 |
2 | Sulfur relay system_Homo sapiens_hsa04122 | 4.69337557 |
3 | Glutathione metabolism_Homo sapiens_hsa00480 | 4.65992246 |
4 | African trypanosomiasis_Homo sapiens_hsa05143 | 4.44108547 |
5 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.99808579 |
6 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 3.64782426 |
7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.55364134 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.36859123 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.88989242 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58606579 |
11 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.47733421 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.26245244 |
13 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.95180776 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79757817 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78848919 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78595264 |
17 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.76058632 |
18 | Taste transduction_Homo sapiens_hsa04742 | 1.69690484 |
19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69567552 |
20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.68364878 |
21 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.50099068 |
22 | Morphine addiction_Homo sapiens_hsa05032 | 1.39423468 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.38066540 |
24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34604453 |
25 | Phototransduction_Homo sapiens_hsa04744 | 1.34194578 |
26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.33235293 |
27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23207249 |
28 | Insulin secretion_Homo sapiens_hsa04911 | 1.20650198 |
29 | Salivary secretion_Homo sapiens_hsa04970 | 1.18570849 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.17896163 |
31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17461460 |
32 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.14364254 |
33 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.14150239 |
34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12386469 |
35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11842738 |
36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09847361 |
37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09799333 |
38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08941382 |
39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.07532306 |
40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05683412 |
41 | Renin secretion_Homo sapiens_hsa04924 | 1.03224562 |
42 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.02395554 |
43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02354728 |
44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00468556 |
45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98261072 |
46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96041817 |
47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89429406 |
48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88578809 |
49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88071823 |
50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87532226 |
51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87518765 |
52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87392452 |
53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86048044 |
54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83243327 |
55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81176854 |
56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80641683 |
57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79313038 |
58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78962894 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76941611 |
60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76814299 |
61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74289484 |
62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74260429 |
63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72117284 |
64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71941766 |
65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70863496 |
66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70159386 |
67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70118373 |
68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69431240 |
69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69076216 |
70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67992010 |
71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66929384 |
72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66801771 |
73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66777109 |
74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66714793 |
75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65739473 |
76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65354871 |
77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64948503 |
78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63928432 |
79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63676614 |
80 | RNA degradation_Homo sapiens_hsa03018 | 0.62958751 |
81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62814200 |
82 | Ribosome_Homo sapiens_hsa03010 | 0.62225800 |
83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62164075 |
84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61106053 |
85 | Prion diseases_Homo sapiens_hsa05020 | 0.60601856 |
86 | Allograft rejection_Homo sapiens_hsa05330 | 0.60572205 |
87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60534344 |
88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60162851 |
89 | Melanogenesis_Homo sapiens_hsa04916 | 0.60123695 |
90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59717127 |
91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59447131 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58343307 |
93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58168246 |
94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57457058 |
95 | Pertussis_Homo sapiens_hsa05133 | 0.54465394 |
96 | RNA polymerase_Homo sapiens_hsa03020 | 0.53907743 |
97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51677359 |
98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50907830 |
99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50352152 |
100 | Bile secretion_Homo sapiens_hsa04976 | 0.50180818 |
101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49243543 |
102 | Hepatitis C_Homo sapiens_hsa05160 | 0.49066652 |
103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48786772 |
104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48314301 |
105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48119158 |
106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47935330 |
107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46577465 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46249496 |
109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45787793 |
110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.44439142 |
111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43178167 |
112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43134203 |
113 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42937678 |
114 | Purine metabolism_Homo sapiens_hsa00230 | 0.42364020 |
115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42305680 |
116 | Glioma_Homo sapiens_hsa05214 | 0.41645583 |
117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41189774 |
118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40790796 |
119 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40320304 |
120 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40302371 |
121 | Gap junction_Homo sapiens_hsa04540 | 0.39540981 |
122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39494722 |
123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39266156 |
124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39006168 |
125 | Phagosome_Homo sapiens_hsa04145 | 0.38751139 |
126 | Insulin resistance_Homo sapiens_hsa04931 | 0.38565663 |
127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38504290 |
128 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38064742 |
129 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37587117 |
130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37129955 |
131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36257804 |
132 | Tuberculosis_Homo sapiens_hsa05152 | 0.35923486 |
133 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35400786 |
134 | Malaria_Homo sapiens_hsa05144 | 0.35045022 |
135 | Platelet activation_Homo sapiens_hsa04611 | 0.33263028 |
136 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32992251 |
137 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32863435 |
138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32704012 |
139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32305280 |
140 | Peroxisome_Homo sapiens_hsa04146 | 0.32218668 |
141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31403449 |
142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31330967 |
143 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31067893 |
144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30392287 |
145 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30266611 |
146 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30197109 |
147 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30161491 |
148 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29926449 |
149 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.29744795 |
150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29392532 |
151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28411604 |
152 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28258748 |
153 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28036025 |
154 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.27520541 |
155 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26621421 |
156 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25113630 |
157 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24619692 |
158 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.22951304 |
159 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22832587 |
160 | ABC transporters_Homo sapiens_hsa02010 | 0.22759898 |
161 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22724235 |
162 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.22709418 |
163 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.20861878 |
164 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20830331 |
165 | Focal adhesion_Homo sapiens_hsa04510 | 0.20443509 |